Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Tests begin of flu vaccine grown in insect cell lines

26.10.2004


Scientists are launching a research study to check the effectiveness of a new type of flu vaccine that is made differently than the conventional vaccine, which is grown in eggs. The experimental vaccine instead relies on a cell line drawn from insects known as silk moths, which are better known for their role as pests attacking crops such as corn, cotton, barley and alfalfa.



The study of FluBlOk, made by Protein Sciences Corp. of Meriden, Ct., was initiated by flu expert John Treanor, M.D., professor of medicine and director of the Vaccine and Treatment Evaluation Unit at the University of Rochester Medical Center. The study will include a total of 400 to 500 adults ages 18 to 49 at three sites: Rochester, the University of Virginia, and Cincinnati Children’s Hospital.

Since the 1940s the chicken has been at the center of flu vaccination efforts, because fertilized chicken eggs are used to grow the flu viruses used in vaccines. Each egg contains less than a teaspoonful of material that will ultimately become part of a vaccine. Because of the complexity and sheer size of the process – tens of millions of eggs must be produced, and vaccine material must be "harvested" from each – it’s typically a six-month process to produce enough vaccine for the public, when everything goes well.


Using a cell line instead of eggs to produce the vaccine would likely slice one or two months off the production process, says Treanor. That could reduce costs and also give scientists and physicians more time each year before they decide on that year’s vaccine makeup, giving them crucial time to watch the spread of flu of around the globe and concoct a vaccine. Producing biological products in insect cell lines is common; the hepatitis B vaccine, for instance, is produced by human cell lines, and scientists from Rochester have developed an experimental vaccine against human papilloma virus using an insect cell line.

Reduced costs might also make it possible to boost the dose that patients receive. Last year in a study of the same product in 399 elderly people, Treanor found that people who had received more vaccine made twice as many antibodies to ward off flu than healthy people who got the conventional vaccine.

The new study is only for healthy people ages 18 through 49 who will not be getting a flu shot otherwise. The study will not include anyone from high-risk groups, such as pregnant women, people with pulmonary disease, the elderly, or health care workers. Those people should be vaccinated with conventional vaccine, which is known to work; the current study is testing an experimental vaccine to see whether it’s effective.

Tom Rickey | EurekAlert!
Further information:
http://www.rochester.edu

More articles from Life Sciences:

nachricht MicroRNA helps cancer evade immune system
19.09.2017 | Salk Institute

nachricht Ruby: Jacobs University scientists are collaborating in the development of a new type of chocolate
18.09.2017 | Jacobs University Bremen gGmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>